Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001736730-25-000058
Filing Date
2025-06-27
Accepted
2025-06-27 16:02:54
Documents
1
Period of Report
2025-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1751054565.html 4  
1 FORM 4 wk-form4_1751054565.xml 4 4082
  Complete submission text file 0001736730-25-000058.txt   5612
Mailing Address C/O 5AM VENTURE MANAGEMENT, LLC 4 EMBARCADERO CENTER, SUITE 3110 SAN FRANCISCO CA 94111
Business Address
Schwab Andrew J. (Reporting) CIK: 0001598549 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42365 | Film No.: 251086205

Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Issuer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)